Bethan Hughes investigates how the Chinese government's efforts to boost innovation have resulted in drug discovery research collaborations between Chinese academic institutions and multinational pharmaceutical companies.
This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
China spurs pharma innovation. Nat Rev Drug Discov 9, 581–582 (2010). https://doi.org/10.1038/nrd3238
Issue Date:
DOI: https://doi.org/10.1038/nrd3238
- Springer Nature Limited
This article is cited by
-
Contract Research Organizations (CROs) in China: integrating Chinese research and development capabilities for global drug innovation
Globalization and Health (2014)
-
Public funding and private investment for R&D: a survey in China’s pharmaceutical industry
Health Research Policy and Systems (2014)
-
Bibliometrics evaluation of research performance in pharmacology/pharmacy: China relative to ten representative countries
Scientometrics (2013)